Scientists state that obtaining funding for research on marijuana is challenging due to its classification as a Schedule 1 drug by the U.S. government, which categorizes it alongside substances like heroin and cocaine and considers it to have no medical value. Moreover, a publication from 2015 in the journal Current Pain and Headache Reports highlights the scarcity of rigorous clinical studies that meet the criteria of being high-quality, randomized, double-blind, and placebo-controlled, which assess the effectiveness of marijuana.
About the Author
Our deep love of plants and fascination with Cannabis has enabled over 25 years of successful small-scale Marijuana cultivation from indoor hydroponics, greenhouses, and outdoor growing set-ups.
As Cannabis laws around the world change, *we support the movement toward freedom of choice for responsible, consenting adults who wish to experience the joy and wonder of growing a Cannabis plant.